DNOW Reports Second Quarter 2026 Results

DNOW reported Q2 revenue of $1,307m, a 10% sequential increase, and adjusted EBITDA of $60m (up 54% sequentially). The quarter generated $133m of operating cash flow and improved net debt leverage to 1.7x, while DNOW repurchased $25m of shares in Q2 and $75m year-to-date under its $160m program. Despite a GAAP net loss of $21m (vs. $14m net income in the prior quarter), management highlighted improved collections, inventory streamlining, and stronger volumes as the key drivers for performance going into 2H.

Analysis

This reads less like a pure operating re-rate and more like a cash-conversion reset. For a distributor, the stock usually trades on working-capital credibility first and reported EPS second; a quarter that pairs positive operating cash flow with active repurchases can support multiple expansion even if GAAP remains noisy. The key market mechanism is that buybacks become more powerful when leverage is already near the low end of what creditors tolerate, because equity is effectively getting paid to wait for margin normalization.

The second-order winner is DNOW’s own equity relative to lower-quality industrial distributors with weaker balance sheets and less room to recycle inventory. MRC Global is the most obvious public comp: if DNOW is genuinely pulling cash out of receivables and inventory while still growing, investors will start to discriminate between distributors with real FCF and those that are still funding growth through the balance sheet. The potential loser is not just competitors, but suppliers who may face tougher pricing and tighter inventory terms if DNOW uses scale and liquidity to press for better economics.

The contrarian risk is that the market may be extrapolating a working-capital bounce into a durable earnings inflection. If the next quarter shows cash conversion reverting toward neutral and adjusted margins fail to hold, the stock can give back gains quickly because the valuation support is cash-flow-driven, not earnings-driven. Time horizon matters: near-term the support is technical and mechanical; over 6-18 months the thesis only works if normalized EBITDA and free cash flow both stay above current run-rate despite commodity/industrial volatility.

Key Decisions for Investors

• Long DNOW on post-earnings weakness for a 1-3 month trade; expect the market to reward cash generation and buyback capacity more than the headline loss. Use a tight stop if operating cash flow falls back below roughly $50mm next quarter.
• Pair trade: long DNOW / short MRC Global (MRC) for 1-3 months. Thesis is that DNOW’s balance sheet and repurchase program should command a premium if working-capital efficiency is real; exit if MRC shows a sharper cash-flow inflection or DNOW margin quality deteriorates.
• Set a catalyst alert around the next quarter’s receivables/inventory trends. If free cash flow turns negative again or leverage moves back above ~2.0x, fade the move and expect the multiple to compress.
• If the stock gaps up hard on the print, consider trimming into strength rather than chasing. The upside case is already partly a balance-sheet story; without follow-through in margins, the risk/reward becomes less attractive.